Sofosbuvir

Records for this ingredient, by country (identity only).

ATC J05AP08 · 12 markets · 81 records

Sofosbuvir 12 markets · 81 records Forms
Filters
MarketUS 15GB 15CN 9AU 8ES 8FR 7CA 4TW 4EU 4SG 2HK 2MX 1
Kind

US 15 records · 9 shown of 13 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusaSofosbuvir and Velpatasvir also in GB·AU·ES
    +3Other 3 marketsFRCASG
  • 400 mgtablet CombinationLedipasvir 90 mg + Sofosbuvir 400 mgHarvoniManufacturer: Asegua Therapeutics LLC also in GB·ES·FR
    +1Other 1 marketsCA
  • 200 mgtablet CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa also in GB·FR
  • 200 mgtablet CombinationLedipasvir 45 mg + Sofosbuvir 200 mgHarvoni also in GB
  • 200 mgpellet CombinationLedipasvir 45 mg + Sofosbuvir 200 mgHarvoni
Other strengths: 4 · 2 dosage forms Otras concentraciones: 4 · 2 formas farmacéuticas 其余规格 4 个 · 涉及 2 种剂型 其餘規格 4 個 · 涉及 2 種劑型
tablet · 1400 mg
pellet · 3200 mg150 mg150 mg

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 15 records · 9 shown of 13 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

Combination products containing this ingredient

  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusaManufacturer: Gilead Sciences Ltd also in US·AU·ES
    +3Other 3 marketsFRCASG
  • 400 mgtablet CombinationLedipasvir 90 mg + Sofosbuvir 400 mgHarvoni also in US·ES·FR
    +1Other 1 marketsCA
  • 200 mgtablet CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa also in US·FR
  • 200 mgtablet CombinationLedipasvir 45 mg + Sofosbuvir 200 mgHarvoni also in US
  • 200 mgpowder CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa 200mg/50mg granules sachets also in FR
Other strengths: 4 · 2 dosage forms Otras concentraciones: 4 · 2 formas farmacéuticas 其余规格 4 个 · 涉及 2 种剂型 其餘規格 4 個 · 涉及 2 種劑型
tablet · 1400 mg
powder · 3200 mg150 mg150 mg

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CN 9 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 400 mgtablet索华迪索磷布韦Manufacturer: 北京凯因格领生物技术有限公司、Manufacturer: 南京正大天晴制药有限公司、Manufacturer: 吉林四环制药有限公司、Manufacturer: 山东世博金都药业有限公司 also in US·GB·ES
    +3Other 3 marketsFRCATW

AU 8 records · 3 shown of 3 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusaEPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle also in US·GB·ES
    +3Other 3 marketsFRCASG
     unknown
  • 400 mgtablet CombinationLedipasvir Acetone Solvate 95.9 mg + Sofosbuvir 400 mgHARVONI ledipasvir/sofosbuvir 90 mg/400 mg tablet bottle unknown
  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVoseviVOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle also in US·GB·FR
    +2Other 2 marketsCASG
     unknown
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Epclusa ×6Harvoni ×4Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 8 records · 6 shown of 6 Source CIMA (AEMPS) · Data as of live

Only this ingredient

Combination products containing this ingredient

  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa also in US·GB·AU
    +3Other 3 marketsFRCASG
  • 400 mgtablet CombinationLedipasvir 90 mg + Sofosbuvir 400 mgHarvoni also in US·GB·FR
    +1Other 1 marketsCA
  • 200 mg per mL / per unit basis not statedliquid CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa
  • 150 mg per mL / per unit basis not statedliquid CombinationSofosbuvir 150 mg + Velpatasvir 37.5 mgEpclusa
  • 100 mgtablet CombinationSofosbuvir 100 mg + Velpatasvir + VoxilaprevirVosevi

FR 7 records · 6 shown of 7 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 400 mgtabletSOVALDI 400 mg, comprimé pelliculé also in US·GB·CN
    +3Other 3 marketsESCATW

Combination products containing this ingredient

Other strengths: 1 · 1 dosage forms Otras concentraciones: 1 · 1 formas farmacéuticas 其余规格 1 个 · 涉及 1 种剂型 其餘規格 1 個 · 涉及 1 種劑型
tablet · 1400 mg

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 4 records · 4 shown of 4 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa also in US·GB·AU
    +3Other 3 marketsESFRSG
  • 400 mgtablet CombinationLedipasvir 90 mg + Sofosbuvir 400 mgHarvoni also in US·GB·ES
    +1Other 1 marketsFR
  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in US·GB·AU
    +2Other 2 marketsFRSG

TW 4 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Epclusa ×6Harvoni ×4Vosevi ×6夏奉寧膜衣錠 ×1宜譜莎 膜衣錠 ×1沃士維膜衣錠 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 4 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Epclusa ×6Harvoni ×4Sovaldi ×4Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa also in US·GB·AU
    +3Other 3 marketsESFRCA
  • 400 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in US·GB·AU
    +2Other 2 marketsFRCA

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Epclusa ×6Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Also called: 索非布費、索非布韋 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.